The global self-monitoring blood glucose devices market is expected to register significant growth in the forecoming years. Major factors driving growth of the global self-monitoring blood glucose devices markets are, rising health care expenditure and increasing prevalence and incidences of life threating disease such as diabetes, etc. across the globe. In addition, growing population, government initiatives, favorable reimbursement policies are the other factors expected to drive the growth of the target market over the forecast period.

The global self-monitoring blood glucose devices market report has been segmented on the basis of product, application, end user, and region.

On the basis of product, the global self-monitoring blood glucose devices market has been segmented into test strips, lancets, and blood glucose meters.

On the basis of application, the global self-monitoring blood glucose devices market has been segmented into type 1 diabetes, type 2 diabetes, and gestational diabetes.

On the basis of end user, the global self-monitoring blood glucose devices market has been segmented into hospitals, home settings, and diagnostic centers.

On the basis of region, the global self-monitoring blood glucose devices markets segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.

Request For The Sample Report Here: https://marketresearch.biz/report/self-monitoring-blood-glucose-devices-market/request-sample/

In 2018, North America self-monitoring blood glucose devices market is expected to account for major share in the global market in terms of revenue, and is expected to maintain its dominance over the forecast period, due to developed medical facilities, rising health care expenditure, favorable reimbursement policies in country in the region. However, Asia Pacific self-monitoring blood glucose devices market is projected to register highest CAGR in the next five years, due to increased health awareness among consumers and rising incidence of obesity in countries in the region.

Key players operating in the global self-monitoring blood glucose devices market includes Abbott Laboratories, Becton, Dickinson and Company (BD), B. Braun Melsungen AG, Johnson & Johnson (Ethicon Inc.), Novo Nordisk A/S, B. Braun Melsungen AG, F. Hoffmann-La Roche Ltd., PHC Holdings Corporation, Sanofi S.A, Terumo Corporation, and Trividia Health, Inc.

Leave a Reply

Your email address will not be published. Required fields are marked *

%d bloggers like this: